The CDC’s preliminary study, which involved approximately 4,600 people, will be updated when the flu season ends.
Here are four things to know.
1. The vaccine’s effectiveness against H3N2, this season’s dominant strain, was lower than the overall effectiveness, at 25 percent.
2. The report estimated the vaccine was 42 percent effective against influenza B viruses and 67 percent effective against H1N1 viruses.
3. Vaccine effectiveness was 59 percent for children aged six months to eight years and 33 percent for those aged 18 to 49 years. The study found no statistically significant protection in other age groups.
4. The CDC reported last week that approximately 10 percent of hospitalizations in the U.S. are due to flu cases. As of last week, the season had not yet peaked.
More articles on infection control:
DC health officials fault United Medical Center for care lapses contributing to patient death: 5 things to know
New York City, New Jersey parents call for transparency on child flu deaths
Surgical patients in low-income countries more likely to develop an infection: 3 findings
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.